May 22, 2023
Astellas Pharma President and CEO Naoki Okamura on May 19 expressed his confidence about a strong takeoff of Veozah (fezolinetant), the company’s newly approved nonhormonal therapy for menopausal symptoms, highlighting its blockbuster potential in the medium to long term. “We...read more